LMR Partners LLP
Q2 2025 13F-HR Holdings
Net value change ($000)
+3,278,169
(30.7%)
New positions
195
Sold out positions
274
Turnover %
44.7%
Sector allocation + QoQ delta (equities-only)
Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown
Snapshot: Change Analysis
Compared to Q1 2025
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| MUB | 176,954 | 2097.9% |
| INFY | 106,233 | NEW |
| NVDA | 83,265 | 201.2% |
| KEL | 72,465 | 1795.9% |
| AVGO | 65,793 | 561.4% |
| AMZN | 65,079 | 15205.4% |
| BPMC | 49,795 | 5263.7% |
| BABA | 48,296 | 339.6% |
| TXNM | 48,291 | NEW |
| WDC | 48,163 | 120.8% |
Top Reduces (Value $000, Stocks/ETFs)
| Intra-Cellular Therapies, Inc. | -113,865 | -100.0% |
| HDB | -97,727 | -100.0% |
| IWM | -55,343 | -100.0% |
| INTC | -47,764 | -96.6% |
| ROP | -47,744 | -98.3% |
| NTNX | -43,049 | -100.0% |
| MONEYLION INC | -41,954 | -100.0% |
| H&E Equipment Services, Inc. | -32,793 | -100.0% |
| KWEB | -31,419 | -100.0% |
| ADSK | -30,827 | -98.1% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
7,552,540
(54.1% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|